On Friday shares of Cellular Biomedicine Group Inc. (NASDAQ:CBMG) closed at $23.96. Company’s sales growth for last 5 years was 43.10%. On April 30, Cellular Biomedicine Group Inc. (NASDAQ:CBMG) announced that it intends to vigorously defend against the claims madeRead More

On Tuesday shares of Clean Energy Fuels Corp. (NASDAQ:CLNE) closed at $6.55. Company’s sales growth for last 5 years was 26.70% and EPS growth for next 5 years is recorded as 25.00%. Clean Energy Fuels Corp. (NASDAQ:CLNE) announced fueling hasRead More

Needham & Company LLC reiterated their hold rating on shares of VIVUS (NASDAQ:VVUS) in a research report sent to investors on 25 February 2015. On Friday shares of VIVUS Inc. (NASDAQ:VVUS) closed at $2.79. Company’s sales growth for last 5Read More

On February 25, Lumber Liquidators Holdings, Inc. (NYSE:LL) reported lower-than-expected fourth-quarter 2014 results. Comparable-store net sales (comps) decreased 4.2%, along with a 1.1% reduction in number of customers invoiced and 5.3% fall in average sales. On Monday shares of LumberRead More

Twenty-First Century Fox, Inc. (NASDAQ:FOXA) announced a cut in its profit forecast. It said a strong dollar and declining advertising revenue, linked to viewers shying away from its broadcast networks, would likely impact revenues. The profit warning put a damperRead More

PDC Energy Inc (NASDAQ:PDCE) has received a Underperform rating from research analysts at Zacks with a rating of 5. On Wednesday shares of PDC Energy, Inc. (NASDAQ:PDCE) closed at $42.41. Company’s sales growth for last 5 years was -6.40% andRead More

Chevron Corporation (NYSE:CVX) announced a significant oil discovery at the Anchor prospect in the deepwater U.S. Gulf of Mexico. Anchor is Chevron’s second discovery in the deepwater Gulf in less than a year, according to Chevron Corporation. On Monday sharesRead More

On 8 January SandRidge Energy, Inc. (NYSE:SD) reported third-quarter net income of $157.3 million, after reporting a loss in the same period a year earlier. The Oklahoma City-based company said it had profit of 27 cents per share. Earnings, adjustedRead More

On 7 January BIND Therapeutics, Inc. (NASDAQ:BIND) announced its 2015 strategic overview and enrollment of the first patient expressing a KRAS mutation in a global, multicenter two-tiered phase 2 trial with BIND-014 in non-small cell lung cancer (NSCLC) patients withRead More

Shares of The Charles Schwab Corporation (NASDAQ:SCHW) have earned an average recommendation of “Hold” from the eleven analysts that are covering the company. One analyst has rated the stock with a sell rating, five have given a hold rating andRead More